樱花视频

Skip to main content
Fig. 5 | 樱花视频

Fig. 5

From: The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in Ethiopia

Fig. 5

The risks of MTCT of HIV with 95% Confidence Intervals among ART regimens. Figure聽5a鈥揷 shows the risks of MTCT of HIV among HIV-Infected pregnant or breastfeeding mothers using Dolutegravir (DTG) or Efavirenz (EFV) based ART regimens during routine PMTCT care (2017鈥�2022) in selected hospitals in Ethiopia; 5a) Perinatal MTCT( N鈥�=鈥�2053), 5b) Breastfeeding MTCT ( N鈥�=鈥�1822) and 5c) end of care MTCT ( N鈥�=鈥�1853)

Back to article page

樱花视频

ISSN: 1471-2458

Contact us